The monoclonal antibody will detect native human TIE-1 in ELISA experiments and on the surface of different human cell types. The antibody can be used for ELISA experiments, Western blotting, FACS and cell sorting.
Produktmerkmale
Chromosomal location: 1p34-p33 The monoclonal antibody was produced with the help of BALB/c mice using recombinant human soluble extracellular TIE-1 as the immunizing antigen.
Aufreinigung
Mouse IgG1 antibody (#8C9) from hybridomas was purified from cell culture supernatant by Protein G chromatography.
TIE1
Reaktivität: Human
WB, ELISA
Wirt: Maus
Monoclonal
3E9
unconjugated
Applikationshinweise
ELISA: Use at 1-15 μg/mL, Western blotting: Use at 1-2 μg/mL
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
Buffer
PBS
Handhabung
Centrifuge vial prior to opening.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
Haltbarkeit
24 months
Target
TIE1
(tyrosine Kinase with Immunoglobulin-Like and EGF-Like Domains 1 (TIE1))
Andere Bezeichnung
TIE-1
Hintergrund
TIE1, TIE, JTK14,TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/Tek comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis.